Literature DB >> 17413044

Beta-catenin downregulation is required for adaptive cardiac remodeling.

Anthony Baurand1, Laura Zelarayan, Russell Betney, Christina Gehrke, Sandra Dunger, Claudia Noack, Andreas Busjahn, Joerg Huelsken, Makoto Mark Taketo, Walter Birchmeier, Rainer Dietz, Martin W Bergmann.   

Abstract

The armadillo-related protein beta-catenin has multiple functions in cardiac tissue homeostasis: stabilization of beta-catenin has been implicated in adult cardiac hypertrophy, and downregulation initiates heart formation in embryogenesis. The protein is also part of the cadherin/catenin complex at the cell membrane, where depletion might result in disturbed cell-cell interaction similar to N-cadherin knockout models. Here, we analyzed the in vivo role of beta-catenin in adult cardiac hypertrophy initiated by angiotensin II (Ang II). The cardiac-specific mifepristone-inducible alphaMHC-CrePR1 transgene was used to induce beta-catenin depletion (loxP-flanked exons 3 to 6, beta-cat(Deltaex3-6) mice) or stabilization (loxP-flanked exon 3, beta-cat(Deltaex3) mice). Levels of beta-catenin were altered both in membrane and nuclear extracts. Analysis of the beta-catenin target genes Axin2 and Tcf-4 confirmed increased beta-catenin-dependent transcription in beta-catenin stabilized mice. In both models, transgenic mice were viable and healthy at age 6 months. beta-Catenin appeared dispensable for cell membrane function. Ang II infusion induced cardiac hypertrophy both in wild-type mice and in mice with beta-catenin depletion. In contrast, mice with stabilized beta-catenin had decreased cross-sectional area at baseline and an abrogated hypertrophic response to Ang II infusion. Stabilizing beta-catenin led to impaired fractional shortening compared with control littermates after Ang II stimulation. This functional deterioration was associated with altered expression of the T-box proteins Tbx5 and Tbx20 at baseline and after Ang II stimulation. In addition, atrophy-related protein IGFBP5 was upregulated in beta-catenin-stabilized mice. These data suggest that beta-catenin downregulation is required for adaptive cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413044     DOI: 10.1161/01.RES.0000266605.63681.5a

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  64 in total

1.  Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.

Authors:  Pamela A Marshall; Zachary Hernandez; Ichiro Kaneko; Tim Widener; Christa Tabacaru; Izayadeth Aguayo; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2012-05-14       Impact factor: 4.292

2.  Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies.

Authors:  Nathan J Palpant; Fikru B Bedada; Brandon Peacock; Bruce R Blazar; Joseph M Metzger; Jakub Tolar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

3.  Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy.

Authors:  Piotr Sklepkiewicz; Takayuki Shiomi; Rajbir Kaur; Jie Sun; Susan Kwon; Becky Mercer; Peter Bodine; Ralph Theo Schermuly; Isaac George; P Christian Schulze; Jeanine M D'Armiento
Journal:  Circ Heart Fail       Date:  2015-02-10       Impact factor: 8.790

4.  Developmental signaling in myocardial progenitor cells: a comprehensive view of Bmp- and Wnt/beta-catenin signaling.

Authors:  Alexandra Klaus; Walter Birchmeier
Journal:  Pediatr Cardiol       Date:  2008-12-20       Impact factor: 1.655

5.  Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct.

Authors:  Dikshya Bastakoty; Sarika Saraswati; Piyush Joshi; James Atkinson; Igor Feoktistov; Jun Liu; Jennifer L Harris; Pampee P Young
Journal:  Cell Stem Cells Regen Med       Date:  2016-05-30

6.  Cdon deficiency causes cardiac remodeling through hyperactivation of WNT/β-catenin signaling.

Authors:  Myong-Ho Jeong; Hyun-Ji Kim; Jung-Hoon Pyun; Kyu-Sil Choi; Dong I Lee; Soroosh Solhjoo; Brian O'Rourke; Gordon F Tomaselli; Dong Seop Jeong; Hana Cho; Jong-Sun Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-02       Impact factor: 11.205

Review 7.  Wnt/β-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target.

Authors:  Habib Haybar; Elahe Khodadi; Saeid Shahrabi
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

8.  Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.

Authors:  Manisha Gupte; Samvruta Tumuluru; Jennifer Y Sui; Anand Prakash Singh; Prachi Umbarkar; Shan S Parikh; Firdos Ahmad; Qinkun Zhang; Thomas Force; Hind Lal
Journal:  Int J Cardiol       Date:  2018-02-03       Impact factor: 4.164

9.  Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation.

Authors:  Laura C Zelarayán; Claudia Noack; Belaid Sekkali; Jana Kmecova; Christina Gehrke; Anke Renger; Maria-Patapia Zafiriou; Roel van der Nagel; Rainer Dietz; Leon J de Windt; Jean-Luc Balligand; Martin W Bergmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

Review 10.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.